Imaging Department, Linyi Central Hospital, Shandong, China.
Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):135-141. doi: 10.26355/eurrev_201801_14110.
To investigate the correlations of the computed tomography (CT) signs of non-small cell lung cancer (NSCLC) with pathological features and the expression levels of phosphoprotein 53 (p53) and c-Myc in patients.
87 patients with NSCLC admitted to the Department of Oncology in our hospital from July 2014 to March 2017 were randomly selected. Morphologies of NSCLC and cancer-adjacent tissues were detected by hematoxylin and eosin (H&E) staining; messenger ribonucleic acid (mRNA) and protein levels of p53 and c-Myc in cancer and cancer-adjacent tissues were detected using real-time polymerase chain reaction (RT-PCR) and immunohistochemistry (IHC); spiral CT (SCT) was conducted for exploring imaging signs of patients with NSCLC; the correlation of CT signs with pathology and the expressions of p53 and c-Myc was analyzed.
H&E staining showed that NSCLC tissues had a larger nucleus, a larger nucleus-cytoplasm ratio, and a more evident histopathological atypia, with no clear histological structure compared with cancer-adjacent normal tissues; RT-PCR and IHC results revealed that the mRNA and protein expression levels of p53 and c-Myc in NSCLC tissues were significantly higher than those in cancer-adjacent tissues, in which differences in mRNA levels were 1.75 folds and 1.84 folds, respectively (p<0.05). SCT signs indicated that swollen lymph nodes and spiculation, spinous process and deep lobulation signs often occurred in the chest of NSCLC patients, and pleural indentation appeared in the majority of patients; the chi-square test results showed that the positive rates of p53 and c-Myc proteins were not related to pathological types of NSCLC, but significantly correlated with tumor differentiation (p<0.05); the positive rates of p53 and c-Myc proteins were correlated with tumor diameter, spiculation and deep lobulation signs and lymph node metastasis (p<0.05), but not associated with spinous process, vacuole and pleural indentation signs (p>0.05).
CT scan combined with the detection of p53 and c-Myc expressions can improve the diagnosis of lymph node metastasis and clinical staging for patients with NSCLC, which is conducive to the clinical treatment and prognosis analysis of NSCLC.
探讨非小细胞肺癌(NSCLC)患者 CT 征象与病理特征及磷酸化蛋白 53(p53)和 c-Myc 表达水平的相关性。
随机选取 2014 年 7 月至 2017 年 3 月我院肿瘤内科收治的 87 例 NSCLC 患者,采用苏木精-伊红(H&E)染色法检测 NSCLC 及癌旁组织形态学,实时聚合酶链反应(RT-PCR)及免疫组化(IHC)法检测癌组织及癌旁组织 p53、c-Myc 信使核糖核酸(mRNA)和蛋白水平,行螺旋 CT(SCT)检查以探讨患者的影像学征象,分析 CT 征象与病理及 p53、c-Myc 表达的相关性。
H&E 染色结果显示,与癌旁正常组织相比,NSCLC 组织的细胞核较大,核浆比较大,组织病理学异型性更为明显,无明显组织学结构;RT-PCR 和 IHC 结果显示,NSCLC 组织中 p53、c-Myc 的 mRNA 和蛋白表达水平明显高于癌旁组织,其中 mRNA 水平差异分别为 1.75 倍和 1.84 倍(均 P<0.05)。SCT 征象提示 NSCLC 患者胸部常出现淋巴结肿大、毛刺、棘突和深分叶征,多数患者出现胸膜凹陷征;卡方检验结果显示,p53、c-Myc 蛋白阳性率与 NSCLC 病理类型无关,但与肿瘤分化程度显著相关(均 P<0.05);p53、c-Myc 蛋白阳性率与肿瘤直径、毛刺及深分叶征、淋巴结转移相关(均 P<0.05),与棘突、空泡及胸膜凹陷征无关(均 P>0.05)。
CT 扫描结合 p53、c-Myc 表达检测可提高 NSCLC 患者淋巴结转移和临床分期的诊断准确率,有助于 NSCLC 的临床治疗和预后分析。